Generic Name : Azacitidine Pronunciation : ay-za-SYE-ti-deen Therapeutic Classification : Chemotherapy ICD Code : Y43.1♦ Safety Labeling Changes Approved By FDA
International- Vidaza. Why it is prescribed (Indications) :
This medication is an antineoplastic agent, prescribed for blood cancer. It slows or stops the growth of cancer cells by killing abnormal cells in the bone marrow. When it is not to be taken (Contraindications):
Contraindicated in patients with advanced liver cancer and hypersensitivity.
Dosage & When it is to be taken :
SC/IV- First Treatment Cycle: The recommended starting dose is 75 mg/m2, daily for 7 days.
Subsequent Treatment Cycles: Cycles should be repeated every 4 weeks. The dose may be increased to 100 mg/m2. How it should be taken :
It comes as a solution for injection to be administered by a healthcare provider into the vein or large muscle. Warnings and Precautions :
* Caution should be exercised in patients with history of kidney or liver problems, any allergy, who are taking other medication, elderly, children, during pregnancy and breastfeeding.
* It may cause dizziness, fainting, or lightheadedness, do not drive a car or operate machinery and get up slowly from bed while taking this medication.
* It may reduce platelet counts; avoid injury or bruising.
* Monitor liver, kidney functions, and blood cell counts regularly while taking this medication.
* Avoid contact with people who have infections. Side Effects :
Most Common - Nausea, anemia, decrease in blood cells, vomiting, pyrexia, diarrhea, injection site redness, constipation and skin discoloration.
Gastrointestinal - Abdominal tenderness, constipation, diarrhea, gum bleeding, loose stools, bleeding of mouth, nausea, vomiting and mouth ulcer.
General - Chest pain, injection site bruising, redness, pain, pigmentation, itching, swelling; lethargy, uneasiness and fever.
Infections - Pneumonia and upper respiratory tract infection.
Metabolic - Loss of appetite.
Musculoskeletal - Joint pain, chest wall pain and muscle pain.
Central Nervous system - Dizziness, headache, anxiety and sleeplessness.
Respiratory - Difficulty in breathing.
Skin - Dry skin, discoloration, redness, rash, scar and hives.
Heart - Blood clot, low blood pressure, and red spots.
♦ Miscellaneous- Tumor lysis syndrome, injection site necrosis and Sweet’s syndrome.
* Avoid excess dosage. Storage Conditions :
Store unreconstituted vials at room temperature (25ºC).
Comment & Contribute
Ask an Expert